Works matching IS 25739832 AND DT 2023 AND VI 5 AND IP 5

Results: 4

Targeting XBP1 mRNA splicing sensitizes glioblastoma to chemotherapy.
Published in:
FASEB Bioadvances, 2023, v. 5, n. 5, p. 211, doi. 10.1096/fba.2022-00141
By:
- Dowdell, Amiee;
- Marsland, Mark;
- Faulkner, Sam;
- Gedye, Craig;
- Lynam, James;
- Griffin, Cassandra P.;
- Marsland, Joanne;
- Jiang, Chen Chen;
- Hondermarck, Hubert
Publication type:
Article
Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis.
Published in:
FASEB Bioadvances, 2023, v. 5, n. 5, p. 199, doi. 10.1096/fba.2022-00121
By:
- Lewis, Caitlin V.;
- Sellak, Hassan;
- Sawan, Mariem A.;
- Joseph, Giji;
- Darby, Trevor M.;
- VanInsberghe, David;
- Naudin, Crystal R.;
- Archer, David R.;
- Jones, Rheinallt M.;
- Taylor, W. Robert
Publication type:
Article
The RNA‐binding protein Snd1/Tudor‐SN regulates hypoxia‐responsive gene expression.
Published in:
FASEB Bioadvances, 2023, v. 5, n. 5, p. 183, doi. 10.1096/fba.2022-00115
By:
- Saarikettu, Juha;
- Lehmusvaara, Saara;
- Pesu, Marko;
- Junttila, Ilkka;
- Partanen, Juha;
- Sipilä, Petra;
- Poutanen, Matti;
- Yang, Jie;
- Haikarainen, Teemu;
- Silvennoinen, Olli
Publication type:
Article
Issue Information.
Published in:
FASEB Bioadvances, 2023, v. 5, n. 5, p. i, doi. 10.1096/fba.1327
Publication type:
Article